Agenda

Initial Agenda Now Available!

The Cell & Gene Meeting on the Med features expert-led panels, in-depth keynote speeches, interactive fireside chats, and 50+ presentations by leading publicly traded and privately held companies from around the globe.

See the initial agenda for the 2019 program below. Please check back soon as this will be continuously updated!

8:00am – 9:00am | REGISTRATION

9:00am | GENERAL SESSION AND PARTNERING OPENS

9:00am – 9:15am

WELCOME AND STATE OF THE INDUSTRY REMARKS {Gaudi 3}

Speaker:

Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM)

9:15am – 9:45am

KEYNOTE ADDRESS {Gaudi 3}

Speaker:

Guido Rasi, Director General, European Medicines Agency (EMA)

9:45am – 10:45am

PLENARY SESSION: COMMERCIAL STRATEGIES FROM PATHFINDERS IN THE INDUSTRY {Gaudi 3}

Chair:

Matthew Durdy, Chief Business Officer, Cell and Gene Therapy Catapult

Speakers:

Dan Faga, Chief Business Officer, Spark Therapeutics
Alison Finger, Chief Commercial Officer, bluebird bio
Owen Marks, Country Lead, Rare Diseases, Pfizer
Derrell Porter, SVP, Global Commercial Head, Atara Biotherapeutics
Pascal Touchon, SVP, Global Head of Cell and Gene Europe, Novartis

10:45am – 11:15am | MORNING BREAK

11:15am – 12:30pm | CONCURRENT TRACKS

COMPANY PRESENTATIONS {Gaudi 3}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

COMPANY PRESENTATIONS {Gaudi 2}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

12:30pm – 1:45pm | LUNCH

1:45pm – 3:30pm | CONCURRENT TRACKS

PANEL: THE PRICING AND REIMBURSEMENT LANDSCAPE: OPPORTUNITIES AND CHALLENGES  {Gaudi 3}
1:45pm – 2:45pm

Speakers:
Luca Alberici, Ph.D., Chief Business Officer, MolMed
Miguel Forte, CEO, Zelluna Immunotherapy
Etienne Jousseaume, Head of Market Access, Cell and Gene Europe, Novartis
Jason Meyenburg, Chief Commercial Officer, Orchard Therapeutics

COMPANY PRESENTATIONS {Gaudi 2}

1:45pm – 2:00pm
2:00pm – 2:15pm
2:15pm – 2:30pm
2:30pm – 2:45pm

COMPANY PRESENTATIONS {Gaudi 3}

2:45pm – 3:00pm
3:00pm – 3:15pm
3:15pm – 3:30pm

COMPANY PRESENTATIONS {Gaudi 2}

2:45pm – 3:00pm
3:00pm – 3:15pm
3:15pm – 3:30pm

3:30pm – 4:00pm | AFTERNOON BREAK

4:00pm – 5:30pm | CONCURRENT TRACKS

SPOTLIGHT SESSION: CELL THERAPY FOR SOLID TUMORS {Gaudi 3}
4:00pm – 4:30pm

Chair:
Alexander Pasteur, Partner, F-Prime Capital
Speaker:
Kimberly Freeman, Vice President, Commercial, Adaptimmune

COMPANY PRESENTATIONS {Gaudi 2}

4:00pm – 4:15pm
4:15pm – 4:30pm

PANEL: MANUFACTURING AND THE CDMO PERSPECTIVE {Gaudi 3}
4:30pm – 5:30pm

Chair:
Thomas Fellner, Ph.D., Head of Cell and Gene Therapy, Lonza
Speakers:
Catherine Cancian, Vice President, Pharmaceutical Operations, GenSight Biologics
Frederic Revah, President, Yposkesi
Joseph Tarnowski, Ph.D., SVP, Cell and Gene Therapy Platform, GSK
Kim Warren, Head of Operations, AVROBIO

COMPANY PRESENTATIONS {Gaudi 2}

4:30pm – 4:45pm
4:45pm – 5:00pm
5:00pm – 5:15pm
5:15pm – 5:30pm

5:30pm | PARTNERING CLOSES

6:30pm – 9:30pm | NETWORKING BASH
Lokal Restaurant Terrace and Garden

8:00am – 9:00am | REGISTRATION

9:00am | GENERAL SESSION AND PARTNERING OPENS

9:00am – 9:15am

WELCOME REMARKS {Gaudi 3}

Speaker:

Matthew Patterson, Chairman and CEO, Audentes Therapeutics; Chairman, Alliance for Regenerative Medicine (ARM)

PANEL: RECENT DEVELOPMENTS AND PREDICTIONS FOR THE FUTURE OF ADVANCED THERAPIES  {Gaudi 3}
9:15am – 10:15am

Chair:
Morrie Ruffin, Co-Founder and Senior Advisor, Alliance for Regenerative Medicine (ARM)
Speakers:
John Tchelingerian, CEO, Promethera Biosciences
Christopher Vann, Chief Operating Officer, Autolus Therapeutics
Rogerio Vivaldi, M.D., President and CEO, Sigilon Therapeutics

COMPANY PRESENTATIONS {Gaudi 2}

9:15am – 9:30am
9:30am – 9:45am
9:45am – 10:00am
10:00am – 10:15am

SPOTLIGHT SESSION {Gaudi 3}
10:15am – 10:45am

COMPANY PRESENTATIONS {Gaudi 2}

10:15am – 10:30am
10:30am – 10:45am

10:45am – 11:15am | MORNING BREAK

11:15am – 12:30pm | CONCURRENT TRACKS

COMPANY PRESENTATIONS {Gaudi 3}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

COMPANY PRESENTATIONS {Gaudi 2}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

12:30pm – 1:45pm | LUNCH

1:45pm – 3:00pm | CONCURRENT TRACKS

PANEL: EUROPEAN CLINICAL TRIALS IN A GLOBAL CONTEXT {Gaudi 3}
1:45pm – 2:30pm

Chair:
Timothy Schroeder, CEO, CTI Clinical Trial & Consulting Services
Speakers:
Ian Hudson, M.D., Chief Executive, Medicines and Healthcare Products Regulatory Agency
Ilona Reischl, Ph.D., Institute Surveillance, Federal Office for Safety in Health Care, Austrian Agency for Health and Food Safety
Martina Schüssler-Lenz, M.D., Chair, EMA Committee for Advanced Therapies, Paul-Ehrlich-Institut
Katsuaki Ura, Deputy Director, Office of International Regulatory Affairs, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare

COMPANY PRESENTATIONS {Gaudi 2}

1:45pm – 2:00pm
2:00pm – 2:15pm
2:15pm – 2:30pm

FIRESIDE CHAT: REGULATING ATMPs IN A POST BREXIT WORLD {Gaudi 3}
2:30pm – 3:00pm

Chair:
Keith Thompson, CEO, Cell and Gene Therapy Catapult
Speaker:
Ian Hudson, M.D., Chief Executive, Medicines and Healthcare Products Regulatory Agency

COMPANY PRESENTATIONS {Gaudi 2}

2:30pm – 2:45pm
2:45pm – 3:00pm

3:00pm – 3:30pm | AFTERNOON BREAK

3:30pm – 4:30pm | CONCURRENT TRACKS

COMPANY PRESENTATIONS {Gaudi 3}

3:30pm – 3:45pm
3:45pm – 4:00pm
4:00pm – 4:15pm
4:15pm – 4:30pm

COMPANY PRESENTATIONS {Gaudi 2}

3:30pm – 3:45pm
3:45pm – 4:00pm
4:00pm – 4:15pm
4:15pm – 4:30pm

4:30pm | PARTNERING CLOSES

6:00pm – 8:00pm | WINE TASTING & RECEPTION
Arola Restaurant

8:00am – 11:00am | ARM EU COMMITTEE MEETINGS
Open to ARM Members Only

By using this website you agree to accept our Privacy Policy and Terms & Conditions